| Market Cap | ₹1,564Cr | 
| ROE | 14.45% | 
| P/E Ratio(TTM) | 27.28 | 
| EPS(TTM) | 0.61 | 
| P/B Ratio | 4.57 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.63 | 
| Book Value | 3.64 | 
| Debt to Equity | 0.01 | 
| Face Value | 1 | 
| Parent Organisation | Syncom Formulations (india) | 
| Managing Director | Shri. Vijay Bankda | 
| NSE Symbol | SYNCOMF | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%)  | 61.33  | ||
| Gland Pharma | NA (0.00%)  | 42.19  | ||
| Ajanta Pharma | NA (0.00%)  | 32.58  | ||
| Eris Lifesciences | NA (0.00%)  | 52.95  |